to lessen the potential risk of significant cardiovascular activities for instance death, heart attack, or stroke in Older people with known heart disease and with either obesity or overweight.Wegovy® contains semaglutide and really should not be made use of with other semaglutide-made up of products and solutions or other GLP-1 receptor agonist m